Aspirin in primary prevention still unclear

The jury is still out on whether aspirin has a role to play in the prevention of cardiovascular events in people at moderate risk, late breaking results from the ARRIVE study reveal. Presented by Professor J Michael Gaziano of the Brigham and Women’s Hospital, Boston, Massachusetts in a Hot Line session at the ESC congress ...

Already a member?

Login to keep reading.

© 2021 the limbic